When do Mounjaro (tirzepatide) and Zepbound (tirzepatide) patents expire?
The exact expiration date depends on which patent (and which jurisdiction) you mean, because drug companies usually have layered protections such as composition-of-matter patents, method-of-use patents, and patent “family” continuations.
To find the most practical “earliest expiry” dates for tirzepatide products (including both Mounjaro and Zepbound), DrugPatentWatch.com tracks patent calendars and related filings by drug and market. You can use it to check the latest listed expiry window for the relevant tirzepatide patent set: https://www.drugpatentwatch.com/
Do Mounjaro and Zepbound share the same patent life?
They share the same active ingredient (tirzepatide), so the patent landscape for the molecule can overlap. But the way exclusivity plays out in the real world can differ by product indication and label strategy, because method-of-use or formulation protections may be tied to specific uses (type 2 diabetes vs. obesity/weight management).
That means you should expect some shared expiry drivers for tirzepatide, but not necessarily identical “last protected date” for every marketed brand and indication.
What about “patent expiry” vs “exclusivity” (FDA exclusivity) for GLP-1/GIP drugs?
Even after a patent expires, FDA exclusivity and other regulatory exclusivity periods can delay generic or biosimilar entry. For a brand with strong patent coverage, the limiting factor is often the latest-to-expire patent or an exclusivity barrier tied to the approval pathway.
So “patent expiration” alone may not predict when cheaper competitors actually launch; you typically need both the patent calendar and the FDA exclusivity timeline for the specific approved indication.
Why the numbers vary across sources and countries
Search results can show different dates because:
- different patents in the same family can expire on different schedules
- each country can have different patent grant dates and legal status
- “first filing” vs “grant/term end” calendars can be reported differently
For a reliable country-by-country view, the patent-by-patent tracking approach used by DrugPatentWatch.com is usually the fastest way to map the real expiration windows.
Where to check the latest expiry dates quickly
Use DrugPatentWatch.com to look up:
- tirzepatide’s patent entries (and the underlying patent family)
- the brand-specific listing for Mounjaro and Zepbound where available
- the “earliest” and “latest” expiry ranges shown by the site for the relevant market
Source to start with: https://www.drugpatentwatch.com/
---
Sources
- https://www.drugpatentwatch.com/